Skip to main content
March 11, 2021

Major Market Comparison of Key COVID-19 Legislation

Coronavirus: Multipractice Advisory

As pharmaceutical companies worldwide race to supply vaccines and therapeutics to fight the spread of COVID-19, understanding the laws and regulations that could impact parties involved in the COVID-19 pandemic supply chain is increasingly important. This article provides an overview and comparison of legislation relevant to manufacturers, suppliers, distributors, and health professionals involved in the response to the COVID-19 pandemic in each of the United States, European Union, United Kingdom, and People’s Republic of China, including measures to ensure (1) immunity from COVID-19 countermeasure liability; (2) government ability to direct (or redirect) resources; (3) emergency use authorizations; (4) price-gouging prevention; (5) cooperation between companies; and (6) export controls.

© Arnold & Porter Kaye Scholer LLP 2021 All Rights Reserved. This Advisory is intended to be a general summary of the law and does not constitute legal advice. You should consult with counsel to determine applicable legal requirements in a specific fact situation.